Thyroid Function Tests - Medical Devices Pipeline Assessment, 2019

Published : Nov-2019

No. of Pages : 132

order by fax Inquire before Buying request discount

Table of Contents
1.1 List of Tables 5
1.2 List of Figures 6
2 Introduction 7
2.1 Thyroid Function Tests Overview 7
3 Products under Development 8
3.1 Thyroid Function Tests - Pipeline Products by Stage of Development 8
3.2 Thyroid Function Tests - Pipeline Products by Segment 9
3.3 Thyroid Function Tests - Pipeline Products by Territory 10
3.4 Thyroid Function Tests - Pipeline Products by Regulatory Path 11
3.5 Thyroid Function Tests - Pipeline Products by Estimated Approval Date 12
4 Thyroid Function Tests - Pipeline Products under Development by Companies 13
4.1 Thyroid Function Tests Companies - Pipeline Products by Stage of Development 13
4.2 Thyroid Function Tests - Pipeline Products by Stage of Development 14
5 Thyroid Function Tests Companies and Product Overview 15
5.1 Abbott Diagnostics Company Overview 15
5.1.1 Abbott Diagnostics Pipeline Products & Ongoing Clinical Trials Overview 15
5.2 AXO Science SAS Company Overview 16
5.2.1 AXO Science SAS Pipeline Products & Ongoing Clinical Trials Overview 16
5.3 Beckman Coulter Inc Company Overview 17
5.3.1 Beckman Coulter Inc Pipeline Products & Ongoing Clinical Trials Overview 17
5.4 Canon Medical Systems Corp Company Overview 18
5.4.1 Canon Medical Systems Corp Pipeline Products & Ongoing Clinical Trials Overview 18
5.5 GeneFluidics Inc Company Overview 19
5.5.1 GeneFluidics Inc Pipeline Products & Ongoing Clinical Trials Overview 19
5.6 Immunodiagnostic Systems Holdings plc Company Overview 22
5.6.1 Immunodiagnostic Systems Holdings plc Pipeline Products & Ongoing Clinical Trials Overview 22
5.7 Labsystems Diagnostics Oy Company Overview 23
5.7.1 Labsystems Diagnostics Oy Pipeline Products & Ongoing Clinical Trials Overview 23
5.8 MedMira Inc Company Overview 25
5.8.1 MedMira Inc Pipeline Products & Ongoing Clinical Trials Overview 25
5.9 Novartis AG Company Overview 26
5.9.1 Novartis AG Pipeline Products & Ongoing Clinical Trials Overview 26
5.10 Ohmx Corp Company Overview 27
5.10.1 Ohmx Corp Pipeline Products & Ongoing Clinical Trials Overview 27
5.11 Ortho-Clinical Diagnostics Inc Company Overview 28
5.11.1 Ortho-Clinical Diagnostics Inc Pipeline Products & Ongoing Clinical Trials Overview 28
5.12 Paramedical Srl Company Overview 29
5.12.1 Paramedical Srl Pipeline Products & Ongoing Clinical Trials Overview 29
5.13 Quidel Corp Company Overview 30
5.13.1 Quidel Corp Pipeline Products & Ongoing Clinical Trials Overview 30
5.14 redhot diagnostics AB Company Overview 32
5.14.1 redhot diagnostics AB Pipeline Products & Ongoing Clinical Trials Overview 32
5.15 Shenzhen Mindray Bio-Medical Electronics Co Ltd Company Overview 33
5.15.1 Shenzhen Mindray Bio-Medical Electronics Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 33
5.16 Siemens Healthcare Diagnostics Inc Company Overview 36
5.16.1 Siemens Healthcare Diagnostics Inc Pipeline Products & Ongoing Clinical Trials Overview 36
5.17 Siemens Healthineers AG Company Overview 39
5.17.1 Siemens Healthineers AG Pipeline Products & Ongoing Clinical Trials Overview 39
5.18 SpinChip Diagnostics AS Company Overview 40
5.18.1 SpinChip Diagnostics AS Pipeline Products & Ongoing Clinical Trials Overview 40
5.19 Sysmex Corp Company Overview 41
5.19.1 Sysmex Corp Pipeline Products & Ongoing Clinical Trials Overview 41
5.20 Tecan Group Ltd Company Overview 43
5.20.1 Tecan Group Ltd Pipeline Products & Ongoing Clinical Trials Overview 43
5.21 University Rovira i Virgili Company Overview 44
5.21.1 University Rovira i Virgili Pipeline Products & Ongoing Clinical Trials Overview 44
6 Thyroid Function Tests- Recent Developments 45
6.1 Oct 30, 2019: PerkinElmer announces financial results for the third quarter of 2019 45
6.2 Oct 28, 2019: Roche Diagnostics Announces Matthew Sause As Chief Executive Officer - North America 46
6.3 Oct 23, 2019: Thermo Fisher Scientific reports third quarter 2019 results 46
6.4 Oct 23, 2019: bioMerieux - Third-Quarter 2019 Business Review 48
6.5 Oct 22, 2019: Novartis delivered another strong quarter with double digit sales growth and core1 margin expansion; 2019 sales and profit guidance raised; Beovu launched in US 50
6.6 Oct 22, 2019: bioMerieux - Third quarter 2019 business review 55
6.7 Oct 22, 2019: Veracyte announces third quarter 2019 financial results and business progress 56
6.8 Oct 16, 2019: Abbott reports third-quarter 2019 results 58
6.9 Oct 14, 2019: Canon Medical to launch new division in Dubai, UAE 61
6.10 Sep 05, 2019: Thermo Fisher Scientific elects New Director to Board 61
6.11 Sep 04, 2019: bioMerieux announces First-Half 2019 Results 62
6.12 Aug 29, 2019: Siemens Healthineers announces new Canadian leadership 65
6.13 Aug 21, 2019: PerkinElmer announces leadership succession plan 66
6.14 Jul 30, 2019: Veracyte announces second quarter 2019 financial results 66
6.15 Jul 29, 2019: PerkinElmer announces financial results for the second quarter of 2019 67
6.16 Jul 29, 2019: Siemens Healthineers continues to drive growth forward 68
6.17 Jul 29, 2019: Changes in the Managing Board of Siemens Healthineers 69
6.18 Jul 29, 2019: OBN announce Thermo Fisher Scientific as a new Corporate Sponsor 70
6.19 Jul 24, 2019: Thermo Fisher Scientific reports second quarter 2019 results 71
6.20 Jul 18, 2019: Novartis delivers strong sales, double digit core operating income growth and launches Zolgensma and Piqray in second quarter; sales and profit guidance increased 73
7 Appendix 129
7.1 Methodology 129
7.2 About GlobalData 132
7.3 Contact Us 132
7.4 Disclaimer 132

List of Tables
Table 1: Thyroid Function Tests - Pipeline Products by Stage of Development 10
Table 2: Thyroid Function Tests - Pipeline Products by Segment 11
Table 3: Thyroid Function Tests - Pipeline Products by Territory 12
Table 4: Thyroid Function Tests - Pipeline Products by Regulatory Path 13
Table 5: Thyroid Function Tests - Pipeline Products by Estimated Approval Date 14
Table 6: Thyroid Function Tests Companies - Pipeline Products by Stage of Development 15
Table 7: Thyroid Function Tests - Pipeline Products by Stage of Development 16
Table 8: Abbott Diagnostics Pipeline Products & Ongoing Clinical Trials Overview 17
Table 9: Alinity i Assay - Tg - Product Status 17
Table 10: Alinity i Assay - Tg - Product Description 17
Table 11: AXO Science SAS Pipeline Products & Ongoing Clinical Trials Overview 18
Table 12: Multiplexed Detection - TSH - Product Status 18
Table 13: Multiplexed Detection - TSH - Product Description 18
Table 14: Beckman Coulter Inc Pipeline Products & Ongoing Clinical Trials Overview 19
Table 15: UniCel DxI 600 Access Immunoassay System - TSH (3rd IS) Assay - Product Status 19
Table 16: UniCel DxI 600 Access Immunoassay System - TSH (3rd IS) Assay - Product Description 19
Table 17: Canon Medical Systems Corp Pipeline Products & Ongoing Clinical Trials Overview 20
Table 18: Diagnostic Test - Thyroid Disorders - Product Status 20
Table 19: Diagnostic Test - Thyroid Disorders - Product Description 20
Table 20: GeneFluidics Inc Pipeline Products & Ongoing Clinical Trials Overview 21
Table 21: Free T3 Assay - Product Status 21
Table 22: Free T3 Assay - Product Description 21
Table 23: Free T4 Assay - Product Status 22
Table 24: Free T4 Assay - Product Description 22
Table 25: T3 Assay - Product Status 22
Table 26: T3 Assay - Product Description 22
Table 27: T4 Assay - Product Status 23
Table 28: T4 Assay - Product Description 23
Table 29: Immunodiagnostic Systems Holdings plc Pipeline Products & Ongoing Clinical Trials Overview 24
Table 30: IDS-iSYS Bioactive PTH (1-84) Kit - Product Status 24
Table 31: IDS-iSYS Bioactive PTH (1-84) Kit - Product Description 24
Table 32: Labsystems Diagnostics Oy Pipeline Products & Ongoing Clinical Trials Overview 25
Table 33: Enzymatic Immuno Assay - Neonatal hTSH EIA - Product Status 25
Table 34: Enzymatic Immuno Assay - Neonatal hTSH EIA - Product Description 25
Table 35: Enzymatic Immuno Assay - Neonatal hTSH FEIA Plus - Product Status 27
Table 36: Enzymatic Immuno Assay - Neonatal hTSH FEIA Plus - Product Description 27
Table 37: TSH Point Of Birth - Product Status 27
Table 38: TSH Point Of Birth - Product Description 27
Table 39: MedMira Inc Pipeline Products & Ongoing Clinical Trials Overview 29
Table 40: Reveal TSH Single Test - Product Status 29
Table 41: Reveal TSH Single Test - Product Description 29
Table 42: Novartis AG Pipeline Products & Ongoing Clinical Trials Overview 31
Table 43: Diagnostic Test - Thyroid Stimulating Hormone - Product Status 31
Table 44: Diagnostic Test - Thyroid Stimulating Hormone - Product Description 31
Table 45: Ohmx Corp Pipeline Products & Ongoing Clinical Trials Overview 33
Table 46: Portable POC System - Thyroid Stimulating Hormone - Product Status 33
Table 47: Portable POC System - Thyroid Stimulating Hormone - Product Description 33
Table 48: Ortho-Clinical Diagnostics Inc Pipeline Products & Ongoing Clinical Trials Overview 34
Table 49: Diagnostic Assay - Thyroid Diseases - Product Status 34
Table 50: Diagnostic Assay - Thyroid Diseases - Product Description 34
Table 51: Paramedical Srl Pipeline Products & Ongoing Clinical Trials Overview 35
Table 52: PKL PPC 960 - TRAb - Product Status 35
Table 53: PKL PPC 960 - TRAb - Product Description 35
Table 54: Quidel Corp Pipeline Products & Ongoing Clinical Trials Overview 36
Table 55: Thyretain TBI Reporter BioAssay - Product Status 36
Table 56: Thyretain TBI Reporter BioAssay - Product Description 37
Table 57: redhot diagnostics AB Pipeline Products & Ongoing Clinical Trials Overview 38
Table 58: Diagnostic Kit - Thyroid Hormone - Product Status 38
Table 59: Diagnostic Kit - Thyroid Hormone - Product Description 38
Table 60: Shenzhen Mindray Bio-Medical Electronics Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 39
Table 61: CL-2000i - Anti-TG Test - Product Status 39

List of Figures
Figure 1: Thyroid Function Tests - Pipeline Products by Stage of Development 8
Figure 2: Thyroid Function Tests - Pipeline Products by Segment 9
Figure 3: Thyroid Function Tests - Pipeline Products by Territory 10
Figure 4: Thyroid Function Tests - Pipeline Products by Regulatory Path 11
Figure 5: Thyroid Function Tests - Pipeline Products by Estimated Approval Date 12

Filed in: Pharmaceutical, Pharmaceuticals and Healthcare

Publisher : GlobalData

Name:
Email:
Phone:
Subject:
Comments:

More Reports

Title	Price	Buy Now
Ambulatory EHR Market by Delivery Mode (Cloud-based, On-premise), Application (e-Prescribing, PHM, Health Analytics, Practice, Patient & Referral Management), Practice Size (Large, Small-to-Medium, Solo), End User (Independent) – Global Forecast to 2027 “The ambulatory EHR market is projected to grow at a CAGR of 6.1% between 2022 and 2027.” The global ambulatory EHR market is projected to reach USD 5.7 billion in 2022 to USD 7.7 billion by 2027, at a CAGR of 6.1%during the forecast period. Growth in this market is driven by the opportunities provided by the market such as increasing demand for cloud-based ambulatory EHR market, and shift towards patient-centric healthcare delivery. However, the interoperability issues & data security concerns are some of the challenges that are expected to limit the growth of the market to a certain extent during the forecast period. “Cloud-based was the fastest-growing segment in the delivery mode of ambulatory EHR market in 2021” Cloud-based segment is projected to growth at the hi......	$4950
Pharmaceutical Excipients Market by Product (Organic Chemicals (Carbohydrates), Inorganic Chemicals (Calcium Phosphate)), Functionality (Fillers, Binders, Lubricants, Preservatives), Formulation (Tablets, Capsules, Parenteral) – Global Forecast to 2027 “The pharmaceutical excipients market growth can be attributed to factors such as the rising pharmaceuticals market, advancements in functional excipients, and the growing generics market. The rapidly growing biopharmaceuticals sector will also influence market growth..” The pharmaceutical excipients market is projected to reach USD 11.5 Billion by 2027 from USD 8.6 Billion in 2022, at a CAGR of 5.9% during the forecast period.The growth can be attributed to the expanding pharmaceutical industry which has fueled the drug production thereby increasing consumption rate for excipients. Additionally, factors like functional excipients development and upsurge in generics market is also likely to propel market growth. “The fillers & diluents functionality accounted for the larges......	$
Digital Pharmacy Market by Drug (Rx, OTC), Product (Medicine, Personal Care, Vitamins & Supplements, Diabetes, CVD, Oncology), Platform (Apps, Websites), Business Model (Captive, Franchise, Aggregator), Geographic (Urban, Rural) – Global Forecasts to 2027 “Digital Pharmacy market to register a CAGR of 17.0% during the forecasts period The digital pharmacy market is expected to reach USD 211.9 billion by 2027 from USD 96.5 billion in 2022, at a CAGR of 17.0% during the forecast period. The growth of this market is driven by the growing consumer preference toward buying online medicines during and post COVID-19 pandemic, consolidation in the market and partnerships, and increasing geriatric population. However, patients relying on pharmacists for clinical support and increasing number of illegal pharmacies are expected to restrain the growth of this market during the forecast period. “Over-the-counter (OTC) products segment is estimated to grow at the highest rate during the forecast period” On the basis ofdrug type, t......	$4950
Pharmacy Automation Market by Product (Automated Medication Dispensing & Storage Systems, Table-Top Counters, Retrieval Systems, Medication Compounding), End User (Inpatient, Outpatient (Fast-Track Clinics), Retail Pharmacies) – Global Forecast to 2027 The pharmacy automation market is expected to grow at a CAGR of 7.9% in the forecast period. The pharmacy automation market is projected to reach USD 8.2 billion by 2027 from USD 5.6 billion in 2022, at a CAGR of 7.9% during the forecast period. The growth in this market is attributed to the growing need to minimize medication errors, rapid decentralization of pharmacies, and growing focus on automation to reduce labor costs. However, the stringent regulations that delay product launches can inhibit the growth of this market. Based on product, the automated medication dispensing and storage systems segment holds the largest market share in 2021 Based on products, the pharmacy automation market is segmented into automated medication dispensing and storage systems, automated packagi......	$4950
Topical Drug Delivery Market by Type (Semi-solids (Creams, Gels, Lotions), Solids(Suppositories), Liquids(Solutions), Transdermal products), Route(Dermal, Ophthalmic), Facility of Use (Homecare setting, Hospitals, Burn Centres) – Global Forecast to 2027 The topical drug delivery market is expected to grow at a CAGR of 8.9% in the forecast period. The global topical drug delivery market is projected to reach USD 317.8 billion by 2027 from USD 207.4 billion in 2022, at a CAGR of 8.9%. The growth of this market can largely be attributed to the high prevalence of topical prescription therapy for dry eye diseases, growing focus of pharmaceutical companies on the R&D of smart transdermal drug delivery systems, increase in prevalence of central nervous disorders, rising preference for non-invasive drug delivery methods. “The semi-solid formulation segment accounted for the largest share of the topical drug delivery market, based on product in 2021.” Based on products, the topical drug delivery the market is segmented into ......	$4950
Cognition and Memory Enhancement Market by Product & Service (Cognition & Memory-enhancing Drugs, Brain-boosting Nutraceuticals, Cognitive Assessment & Training Solutions), Region (North America, Europe, Asia Pacific, ROW) – Global Forecast to 2026 “Increasing incidence and prevalence of neurological disorders is a key factors driving growth in the cognition and memory enhancement market’’ The global cognition and memory enhancement market is projected to reach USD 38.9 billion by 2026 from USD 23.4 billion in 2021, at a CAGR of 10.7% during the forecast period. Elevating prevalence of neurological disorders, such as dementia, epilepsy, Parkinson’s disease, Huntington’s disease, headache disorders, multiple sclerosis, neuroinfections, stroke, and cerebral palsy, have increased significantly over the years. “By product & service segment, the cognition & memory-enhancing drugs segment has registered fastest growth rate during the forecast period” Based on product & service, the cognition and memory en......	$4950
High Potency APIs/HPAPI Market by Type (Innovative, Generic), Type of Synthesis (Synthetic, Biotech, Biosimilars, mAbs, Vaccines), Manufacturers (Captive, Merchant), Application (Oncology, Hormonal Imbalance, Glaucoma) Region – Global forecast to 2027 The HPAPI market is projected to reach USD 39.6 Billion by 2027 from USD 24.5 billion in 2022, at a CAGR of 10.1% from 2022 to 2027. The market is driven by increasing demand for oncology drugs, growing demand for antibody-drug conjugates and others. “The innovative HPAPIs segment is expected to account for the largest share of the market in 2021” Based on type, the HPAPI market is segmented into innovative and generic. The innovative segment is expected to account for the largest share of the HPAPI market in 2021. The large share can be attributed to the increased R&D investments. “The Synthetic APIs segment to account for the largest share of the market in 2021” Based on type of synthesis, the market is segmented into synthetic and biotech HPAPIs. The synthetic AP......	$4950
Plasma Fractionation Market by Product (Immunoglobulins, Albumin, Protease Inhibitors, von Willebrand Factor, PCC), Application (Neurology, Immunology, Hematology, Rheumatology), End User (Clinical Research, Hospitals & Clinics) – Global Forecast to 2027 “Increased risk of communicable diseases, Rising prevalence of bleeding disorders in global population, Use of Immunoglobulin’s for a range of neurological conditions, including multiple sclerosis, neuropathic pain, and chronic fatigue syndrome is expected to drive the overall growth of the plasma fractionation market.” The global plasma fractionation market size is projected to reach USD 36.7 billion by 2027 from USD 26.5 billion in 2022, at a CAGR of 6.7% during the forecast period. Market growth is driven mainly by factors such as rapid growth of geriatric population, growing prevalence of respiratory disorders such as alpha-1-antitrypsin deficiency (AATD) and emphysema, and use of plasma fractionation products as first-line therapies for a number of bleeding, hematological, an......	$4950
Patient Engagement Solutions Market by Component (Software, Services), Delivery (On-Premise, Cloud), Therapy Area (CVD, Diabetes, Obesity, Fitness), Functionality (E-prescribing, Virtual care), End User (Provider, Payer, Patients) – Global Forecast to 2027 “Patient engagement solutions market to register a CAGR of 10.0% from 2022 to 2027” The patient engagement solutions market is projected to reach USD 27.9 billion by 2027 from USD 17.3 billion in 2022, at a CAGR of 10.0% during the forecast period. The growth of this market is driven by the adoption and changes in government regulations to promote patient-centric care and involve patients throughout the care journey, high demand for patient engagement solutions, and the growing utilization of m- health apps. However, interoperability issues for patient engagement solutions and a dreadth of skilled IT professionals in the healthcare industry are expected to restrain the growth of this market during the forecast period. “Services segment is expected to grow at the highest rate......	$4950
Healthcare Cloud Computing Market by Product (EMR/EHR, VNA, RIS, LIS, PIS), Deployment (Private Cloud, Hybrid Cloud, Public Cloud), Component (Software, Services), Pricing (Spot Pricing), Service (SaaS, IaaS, PaaS), End User – Global Forecasts to 2027 The global Healthcare cloud computing market is projected to reach USD 89.4 billion by 2027 from USD 39.4 billion in 2022, at a CAGR of 17.8%. The factors driving the market are adoption of technologies like telehealth, EHR, big data analytics, IoT, cloud computing, m health, wearlable devices, etc. “The healthcare provider solution was the largest segment in the healthcare cloud computing market in 2021.” The healthcare provider segment accounted for the larger share of 79.2% of the healthcare cloud computing market in 2021. The growing adoption of various health IT solutions such as EHR, e-prescribing, telehealth, mHealth, and others due to COVID-19 is one of the key factors contributing to the growth of this segment. “Among end users, the healthcare providers segment ac......	$4950

Thyroid Function Tests - Medical Devices Pipeline Assessment, 2019

Benefits of Sandler Research

User License for Reports

Reach Us

Contact Us

Knowledge Store

Email Subscription

our Feed Reader

Ambulatory EHR Market by Delivery Mode (Cloud-based, On-premise), Application (e-Prescribing, PHM, Health Analytics, Practice, Patient & Referral Management), Practice Size (Large, Small-to-Medium, Solo), End User (Independent) – Global Forecast to 2027

Pharmaceutical Excipients Market by Product (Organic Chemicals (Carbohydrates), Inorganic Chemicals (Calcium Phosphate)), Functionality (Fillers, Binders, Lubricants, Preservatives), Formulation (Tablets, Capsules, Parenteral) – Global Forecast to 2027

Digital Pharmacy Market by Drug (Rx, OTC), Product (Medicine, Personal Care, Vitamins & Supplements, Diabetes, CVD, Oncology), Platform (Apps, Websites), Business Model (Captive, Franchise, Aggregator), Geographic (Urban, Rural) – Global Forecasts to 2027

Pharmacy Automation Market by Product (Automated Medication Dispensing & Storage Systems, Table-Top Counters, Retrieval Systems, Medication Compounding), End User (Inpatient, Outpatient (Fast-Track Clinics), Retail Pharmacies) – Global Forecast to 2027

Topical Drug Delivery Market by Type (Semi-solids (Creams, Gels, Lotions), Solids(Suppositories), Liquids(Solutions), Transdermal products), Route(Dermal, Ophthalmic), Facility of Use (Homecare setting, Hospitals, Burn Centres) – Global Forecast to 2027

Cognition and Memory Enhancement Market by Product & Service (Cognition & Memory-enhancing Drugs, Brain-boosting Nutraceuticals, Cognitive Assessment & Training Solutions), Region (North America, Europe, Asia Pacific, ROW) – Global Forecast to 2026

High Potency APIs/HPAPI Market by Type (Innovative, Generic), Type of Synthesis (Synthetic, Biotech, Biosimilars, mAbs, Vaccines), Manufacturers (Captive, Merchant), Application (Oncology, Hormonal Imbalance, Glaucoma) Region – Global forecast to 2027

Plasma Fractionation Market by Product (Immunoglobulins, Albumin, Protease Inhibitors, von Willebrand Factor, PCC), Application (Neurology, Immunology, Hematology, Rheumatology), End User (Clinical Research, Hospitals & Clinics) – Global Forecast to 2027

Patient Engagement Solutions Market by Component (Software, Services), Delivery (On-Premise, Cloud), Therapy Area (CVD, Diabetes, Obesity, Fitness), Functionality (E-prescribing, Virtual care), End User (Provider, Payer, Patients) – Global Forecast to 2027

Healthcare Cloud Computing Market by Product (EMR/EHR, VNA, RIS, LIS, PIS), Deployment (Private Cloud, Hybrid Cloud, Public Cloud), Component (Software, Services), Pricing (Spot Pricing), Service (SaaS, IaaS, PaaS), End User – Global Forecasts to 2027